Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Metaplastic Breast Cancer.

Türkan H, Gökgöz MŞ, Parlak NS.

J Breast Health (2013). 2016 Jan 1;12(1):47-49. doi: 10.5152/tjbh.2015.2505. eCollection 2016 Jan.

2.

Breast Carcinosarcomas.

Yakan S, Sarı E, Erkan N, Yıldırım M, Vardar E, Coşkun A, Çetin DA, Eliyatkın N.

J Breast Health (2013). 2014 Jul 1;10(3):161-165. doi: 10.5152/tjbh.2014.2197. eCollection 2014 Jul.

3.

Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.

Zhou N, Liu C, Hou H, Zhang C, Liu D, Wang G, Liu K, Zhu J, Lv H, Li T, Zhang X.

Oncotarget. 2016 Nov 1;7(44):72373-72379. doi: 10.18632/oncotarget.12568.

4.

SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.

Fan LC, Jeng YM, Lu YT, Lien HC.

PLoS One. 2016 Sep 14;11(9):e0162933. doi: 10.1371/journal.pone.0162933. eCollection 2016.

5.

Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas.

Sircar K, Yoo SY, Majewski T, Wani K, Patel LR, Voicu H, Torres-Garcia W, Verhaak RG, Tannir N, Karam JA, Jonasch E, Wood CG, Tamboli P, Baggerly KA, Aldape KD, Czerniak B.

J Pathol Clin Res. 2015 Jul 7;1(4):212-24. doi: 10.1002/cjp2.23. eCollection 2015 Oct.

6.

Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical study.

Giordano G, Berretta R, Silini E.

Diagn Pathol. 2016 Aug 5;11(1):70. doi: 10.1186/s13000-016-0521-3.

7.

Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.

Leo F, Bartels S, Mägel L, Framke T, Büsche G, Jonigk D, Christgen M, Lehmann U, Kreipe H.

Virchows Arch. 2016 Aug;469(2):191-201. doi: 10.1007/s00428-016-1950-9. Epub 2016 May 25.

8.
9.

Spindle cell carcinoma of the breast as complex cystic lesion: a case report.

Kitada M, Hayashi S, Matsuda Y, Ishibashi K, Oikawa K, Miyokawa N.

Cancer Biol Med. 2014 Jun;11(2):130-3. doi: 10.7497/j.issn.2095-3941.2014.02.008. Erratum in: Cancer Biol Med. 2014 Sep;11(3):216.

10.

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan.

Hashmi AA, Edhi MM, Naqvi H, Faridi N, Khurshid A, Khan M.

Diagn Pathol. 2014 Feb 28;9:43. doi: 10.1186/1746-1596-9-43.

11.

Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.

Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC.

Exp Hematol Oncol. 2013 Nov 14;2(1):31. doi: 10.1186/2162-3619-2-31.

12.

Primary osteosarcoma of breast, a rare case.

Dey S, Chaudhury MK, Basu SK, Manna AK, Dutta SK.

J Clin Diagn Res. 2013 Aug;7(8):1710-1. doi: 10.7860/JCDR/2013/5700.3263. Epub 2013 Aug 1.

13.

Metaplastic carcinoma of the right breast and simultaneous giant ovarian teratoma: a case report.

Li S, Wei QZ.

Chin J Cancer. 2012 Oct;31(10):500-4. doi: 10.5732/cjc.012.10118. Epub 2012 Aug 2.

14.

Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights.

Rungta S, Kleer CG.

Arch Pathol Lab Med. 2012 Aug;136(8):896-900. doi: 10.5858/arpa.2012-0166-CR.

15.

Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations.

Yuan W, Stawiski E, Janakiraman V, Chan E, Durinck S, Edgar KA, Kljavin NM, Rivers CS, Gnad F, Roose-Girma M, Haverty PM, Fedorowicz G, Heldens S, Soriano RH, Zhang Z, Wallin JJ, Johnson L, Merchant M, Modrusan Z, Stern HM, Seshagiri S.

Oncogene. 2013 Jan 17;32(3):318-26. doi: 10.1038/onc.2012.53. Epub 2012 Feb 27.

16.

Giant sarcomatoid carcinoma of the breast - a rare case report.

Singal R, Dalal AK, Dalal U, Attri AK, Gupta S, Gupta N.

Maedica (Buchar). 2011 Jul;6(3):201-3.

17.

Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.

Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL Jr, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ.

Breast Cancer Res Treat. 2012 Jan;131(1):41-8. doi: 10.1007/s10549-011-1393-6. Epub 2011 Feb 18.

18.

Challenges to diagnose metaplastic carcinoma of the breast through cytologic methods: an eight-case series.

Lale S, Kure K, Lingamfelter D.

Diagn Pathol. 2011 Jan 18;6:7. doi: 10.1186/1746-1596-6-7.

19.

Diagnostic utility of snail in metaplastic breast carcinoma.

Nassar A, Sookhan N, Santisteban M, Bryant SC, Boughey JC, Giorgadze T, Degnim A.

Diagn Pathol. 2010 Nov 26;5:76. doi: 10.1186/1746-1596-5-76.

20.

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.

Micalizzi DS, Farabaugh SM, Ford HL.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34. doi: 10.1007/s10911-010-9178-9. Epub 2010 May 19. Review.

Supplemental Content

Support Center